J. Hung et al., ALLELE-SPECIFIC CHROMOSOME 3P DELETIONS OCCUR AT AN EARLY-STAGE IN THE PATHOGENESIS OF LUNG-CARCINOMA, JAMA, the journal of the American Medical Association, 273(7), 1995, pp. 558-563
Background.-Deletions in the short arm of chromosome 3 (3p) are presen
t in most lung carcinomas. Objective.-To investigate the role of these
chromosome 3p deletions in the pathogenesis of non-small cell lung ca
rcinomas. Design.-Seven archival, paraffin-embedded, surgically resect
ed lung cancer specimens were studied. Fifty precisely identified mali
gnant and preneoplastic lesions present in bronchi, bronchioles, and a
lveoli were microdissected from stained slides and analyzed for allele
loss using polymerase chain reaction-based assays for dinucleotide re
peat polymorphisms at three chromosome 3p loci (3p14, 3p21.3, and 3p25
). Setting.-University-based medical center and affiliated hospitals.
Subjects.-Samples were analyzed from seven patients who underwent surg
ical resection with curative intent for non-small cell lung cancer and
whose specimens included extensive multifocal areas of preneoplastic
lesions (hyperplasia, metaplasia, dysplasia, or noninvasive cancer). R
esults.-Lymphocytes from all seven cases were heterozygous (ie, inform
ative) for all three microsatellites analyzed. Six (86%) of seven inva
sive cancers had loss of heterozygosity at one or more chromosome 3p s
ites. In the accompanying preneoplastic lesions, loss of heterozygosit
y was detected in none of two normal bronchioles, 13 (76%) of 17 hyper
plasias, six (86%) of seven dysplasias, and four (100%) of four noninv
asive cancers. Loss of heterozygosity was detected throughout the resp
iratory tract, in bronchi, bronchioles, and alveoli. In 18 (78%) of 23
preneoplastic lesions, the specific alleles lost were identical to th
ose lost in the corresponding carcinomas. The probability of this happ
ening by chance is 5.3x10(-3). Conclusions.-Deletions in the short arm
of chromosome 3 occur at the earliest stage (hyperplasia) in the path
ogenesis of lung cancer and involve all regions of the respiratory tra
ct. Allele loss is highly specific, but its mechanism remains unknown.
Our findings may be of considerable biologic, prognostic, and clinica
l significance.